Malignant Peritoneal Neoplasm Completed Phase 1 Trials for Docetaxel (DB01248)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00268918Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer PatientsTreatment
NCT00692900Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube CancerTreatment